Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.22.4
NET LOSS PER SHARE (Tables)
9 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities
The following outstanding stock-based instruments which are comprised of performance share units, restricted stock units, and warrants were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive (in thousands):

Three Months Ended December 31, Nine Months Ended December 31,
2022 2021 2022 2021
5,450  8,802  3,763  9,811